Haemonetics price target raised to $95 from $89 at Barrington
Upside implied by target raise
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside implied by target raise
What happened, with direct paths to the underlying reporting
Barrington raises HAE target to $95 from $89; current price $85.02.
Target: $95
Posted price: $85.02
Analyst firm: Barrington
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.